Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis

Figure 1 Postoperative survival rate in neoadjuvant chemoradiotherapy and surgery compared with surgery alone. A: One-year survival; B: Three-year survival; C: Five-year survival. CRT + S: Neoadjuvant chemoradiotherapy and surgery; S: Surgery; OR: Odds ratio; CI: Confidence interval.

Figure 2 R0 resection rate in neoadjuvant chemoradiotherapy and surgery compared with surgery alone.

Figure 3 Postoperative mortality in neoadjuvant chemoradiotherapy and surgery compared with surgery alone.

Figure 4 Incidence of postoperative complication in neoadjuvant chemoradiotherapy and surgery compared with surgery alone.

Figure 5 Cancer recurrence after surgery in neoadjuvant chemoradiotherapy and surgery compared with surgery alone. A: Incidence of local-regional cancer recurrence; B: Incidence of distant cancer recurrence.